Main Page Side Effects Insurance Coverage Review Board

Does Blue Cross Blue Shield Colorado Cover Wegovy for Weight Loss?

Does Blue Cross Blue Shield Colorado Cover Wegovy? Colorado BCBS Coverage Guide 2026

Colorado-based patients wondering whether your Blue Cross Blue Shield plan covers Wegovy, it comes down to the formulary tier and plan type. Anthem Blue Cross Blue Shield Colorado administers coverage for millions of Colorado residents, and their formulary handling of Wegovy (the injectable GLP-1 receptor agonist for chronic weight management) is distinct from other state BCBS affiliates.


BCBS Colorado Formulary Status for Wegovy

Anthem Blue Cross Blue Shield Colorado operates a drug list that doesn’t always match BCBS plans in neighboring states. Currently, Wegovy is typically placed on Tier 3 (preferred specialty brand) across the majority of Anthem Blue Cross Blue Shield Colorado commercial plans.

What this translates to:

  • Prior authorization is required across most benefit designs
  • Step therapy could be enforced — requiring trial of formulary-preferred drugs first
  • Copays typically range between $50–$150/month depending on benefit structure
  • Select Colorado employer-sponsored BCBS plans might classify Wegovy at a lower tier

Without insurance, Wegovy costs $1,300–$1,500 per month statewide.


Wegovy Coverage for Diabetes vs. Weight Loss in Colorado

Anthem Blue Cross Blue Shield Colorado’s coverage policies for Wegovy depend heavily on the reason for prescribing.

For chronic weight management (FDA-approved indication):

  • Coverage is the standard path
  • The majority of Colorado BCBS plans authorize Wegovy when medical necessity is demonstrated
  • What you need typically includes failed prior therapy documentation

For weight loss (off-label for some formulations):

  • Approval is harder to obtain
  • You must demonstrate BMI ≥30 (or ≥27 with at least one weight-related comorbidity)
  • Many Colorado plans exclude anti-obesity medications entirely

How to Get Wegovy Approved by BCBS Colorado

Obtaining coverage for Wegovy through Anthem Blue Cross Blue Shield Colorado requires a strategic approach.

  1. Confirm your plan’s formulary — Call the number on your ID card to check Wegovy’s formulary position for your benefit design
  2. Have your prescriber send prior authorization — Include complete clinical documentation
  3. Demonstrate unsuccessful prior therapies — Step therapy typically demands documentation of failed multiple cheaper alternatives first
  4. Appeal if denied — Anthem Blue Cross Blue Shield Colorado allows multiple appeal stages plus Colorado Department of Insurance complaint

A 2024 KFF survey found that approximately 30% of GLP-1 prior authorization requests are initially denied but more than half are overturned on appeal.


Options When Coverage Falls Through

When Anthem Blue Cross Blue Shield Colorado rejects Wegovy coverage, explore other paths:

  • Manufacturer savings programs — Novo Nordisk has patient savings programs that may lower your copay to $25-$150/month for qualifying non-government plan patients
  • Compounded semaglutide — An option in Colorado at $150–$400/month, though not a formulary option
  • Switch to a covered option — Anthem Blue Cross Blue Shield Colorado may prefer another brand
  • Colorado SPAP programs — Look into Colorado provides supplemental prescription programs for high-cost medications

Bottom Line for Colorado BCBS Members

Anthem Blue Cross Blue Shield Colorado may authorize Wegovy — but coverage is plan-specific and often requires meeting specific clinical criteria. Start by reviewing your benefits and coordinating with your doctor to document medical necessity thoroughly.

References

  1. FDA Prescribing Information for GLP-1 receptor agonists. U.S. Food and Drug Administration. 2024.
  2. SURPASS and SURMOUNT clinical trial programs. Eli Lilly and Company. 2022-2025.
  3. SUSTAIN and STEP clinical trial programs. Novo Nordisk. 2017-2024.
  4. American Diabetes Association Standards of Care in Diabetes. 2025.
  5. American Society of Health-System Pharmacists (ASHP) Drug Information. 2025.